Showing results (101-110 of 116) with videos related to
Sort By:
Pageof 12
International Journal of Molecular Sciences|October 18, 2019
Treadmill Running in Established Phase Arthritis Inhibits Joint Destruction in Rat Rheumatoid Arthritis ModelsYuta Fujii, Hiroaki Inoue, Yuji Arai, et al.Molecular Therapy. Oncology|April 20, 2026
Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirusRyohei Shoji, Hiroshi Tazawa, Shinji Kuroda, et al.International Journal of Colorectal Disease|February 4, 2021
Therapeutic significance of D3 dissection for low rectal cancer: a comparison of dissections between the lateral pelvic lymph nodes and the lymph nodes along the root of the inferior mesenteric artery in a multicenter retrospective cohort studyHiroaki Inoue, Kazuhito Sasaki, Hiroaki Nozawa, et al.Cancers|September 5, 2018
Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus RituximabShinya Rai, Hirokazu Tanaka, Ko Fujimoto, et al.International Journal of Hematology|April 17, 2021
Low absolute lymphocyte count is a poor prognostic factor for untreated advanced follicular lymphoma treated with rituximab plus bendamustine: results of the prospective phase 2 CONVERT trialShinya Rai, Hiroaki Inoue, Hitoshi Hanamoto, et al.The British Journal of Nutrition|February 6, 2023
A comparative, randomised MRI study of the physiological and appetitive responses to gelling (alginate) and non-gelling nasogastric tube feeds in healthy menAbdulsalam I Aliyu, Aline Nixon, Caroline L Hoad, et al.NPJ Vaccines|July 19, 2025
Oncolytic virus-mediated p53 activation boosts the antitumor immunity of a p53-transduced dendritic cell vaccineMotohiko Yamada, Hiroshi Tazawa, Kanto Suemori, et al.Internal Medicine (Tokyo, Japan)|April 19, 2019
Usefulness of Ustekinumab for Treating a Case of Myelodysplastic Syndrome-associated Inflammatory Bowel DiseaseMasashi Kono, Toshiharu Sakurai, Kazuki Okamoto, et al.Surgical Case Reports|July 7, 2022
Axillary lymphangioma that developed following COVID-19 vaccination: a case reportSoichiro Sasa, Hiroaki Inoue, Tomohiro Inui, et al.Clinical Breast Cancer|March 10, 2024
Long-Term Outcomes of S-1 Combined With Low-Dose Docetaxel as Neoadjuvant Chemotherapy (N-1 Study, Phase II Trial) in Patients With Operable Breast CancerSoichiro Sasa, Hiroaki Inoue, Misako Nakagawa, et al.Pageof 12